This document provides a summary of Tusneem Ahmed M. Elhassan's qualifications and experience. It includes his personal and contact information, education history with degrees in computer science and statistics, work experience as a research data analyst specializing in oncology, publications and presentations, and training and awards. His current role involves clinical trial design, data analysis, quality improvement, and research committee participation at King Faisal Specialist Hospital in Saudi Arabia.

1. TUSNEEM AHMED M.ELHASSAN
PERSONAL INFORMATION
Nationality : American
Date of Birth : September 6
th
, 1978
Marital Status : Married
Languages : Arabic (mother tongue)
English (fluent in writing, reading and speaking)
Contact : Tel: +966 568627727
+966 504265141 (ref Hassan)
ACADEMIC QUALIFICATIONS
M.Sc. in Computer Sciences, with Major in Software Engineering,
Faculty of Mathematical Sciences – Department of statistics and
Computer Science University of Khartoum, SUDAN (2006 – 2007).
Thesis: Mapping CMM Software Process Improvement Using Extreme programming
(XP) and Rational Unified Programming (RUP) Agile Methods.
B.Sc. (Honors Degree) in Statistics and Computer Science. Faculty
of Mathematical Sciences – Department of statistics and Computer
Science University of Khartoum, SUDAN (1997 – 2002).
WORKING EXPERIENCE:
Current post:
March 2010 - to date (June
2013)
Research Data Analyst, Oncology Center, Research Unit
King Faisal Specialist Hospital (KFSH&RC), Riyadh, Saudi Arabia
Responsibilities:
1

2. - Participating in clinical trials design in term of sample size
calculation, Randomization process, CRF designs, statistical
analysis and Summery reports.
- Providing training to oncology center staff on study design and
statistical data analysis.
- Provide training for data management personnel about database
design and database management systems DBMS.
- Supervise the data management process by reviewing the CRFs
and database design.
- Designing databases to using appropriate data models and
software for different clinical trials and registries.
- Participate in research unit quality improvements through
performing the monthly audit.
- Member of oncology research Committee (CRC): Participating in
protocol development in order to ensure adequacy of the proposed
study designs with respect to statistical feasibility.
- Write statistical methodology sections of individual protocols or
publication.
- Reviewing Proposals assuring that the research question has been
answered and the final conclusion in a lined with statistical analysis
conducted.
- Interact with data management personnel as necessary to ensure
that datasets are in usable format.
Previous Jobs:
Nov 2007 - Feb 2010
 Research Data Analyst, ENT department
King Faisal Specialist Hospital (KFSH&RC), Riyadh, Saudi Arabia.
2

3. Job Description:
- Analysis, interpretation and presentation of quantitative information.
- Development of experimental designs, sampling techniques, and
analytical methods.
- Developing and maintaining the department’s databases (oracle10g
suite and access DMS).
Sep 2007 - Nov 2007
 Lecturer, King Saud University
Riyadh, Saudi Arabia
Teaching courses in quantitative statistics and computer programming.
Jan 2007 - Aug 2007
 Lecturer, Arab Open University
Riyadh, Saudi Arabia,
Teaching Database Analysis and Design. In addition to teaching, my job
responsibilities involve following the Open Learning system; i.e. using
web portal and email facilities in the learning process.
 Lecturer, Aptech College Jan 2003 –
Jan 2006
Khartoum, SUDAN
Teaching all of the subjects mentioned above with focus on statistical
subjects, JAVA programming, Object Oriented Analysis & Design. In
addition to teaching, my job responsibilities involve exam preparation,
results preparation and students attendance control.
July 2002 – Dec 2002
 System Analyst, ZinaNet; a leading ISP company
Khartoum, SUDAN
3

4. Job Description: During this period, as a System Analyst, I have
worked in systems’ requirements management, developing Software
Requirement Specifications (SRS) to be the governing contract between
The organization and its clients. This include, functional requirements
using UML, and non-functional requirements; in addition to project
context, process models, workflow, model, etc.
June-2002
 Project investigator, (part-time)
Description: Applications of statistical analysis using STATA
statistical package for medical students at the faculty of medicine, U of K,
Sudan. This project includes data tabulation and analysis using graphics
and statistical tests in providing statistical conclusions.
June-2002
 Teacher Assistant Faculty of Mathematical Science, University of
Khartoum, (part-time)
Description:
Supervising students in final projects and guiding them doing the
following:
 Data management and statistical analysis using STATA
statistical package.
 How to choose a sample from a large unlimited population using
the sampling techniques and then how to classify and tabulate
data in order to apply the statistical tests and then summarizes the
results in form of reports.
 System analysis and design including requirement analysis using
Unified Modeling language(UML) to create required models such
as and data, process and sequence models
4

5. STATISTICAL CONSOLATION AND RESEARCH EXPERIENCE IN
CLINICAL FIELD (SELECTED PROJECTS):
- Clinical utility in Gastrointestinal (GI) malignancies (Investigator: Dr. Ali
Aljubran)
- Statistical analysis for Molecular classification of Breast Carcinoma by
immunohisto-chemical analysis, Sep 2010.
- Statistical analysis for Breast cancer databases of medical oncology
experience at King Faisal Specialist Hospital and Research Center. The
work was presented by a medical researcher in the International
conference on new frontiers in Breast Cancer, April 2010.
- Statistical analysis of the TP53 mutation in locally advanced breast cancer,
medical oncology at King Faisal Specialist Hospital and Research Center -
presented by a fellow researcher in the International conference on new
frontiers in Breast Cancer, April 2010.
- Statistical analysis for the multi-center prospective phase II trial of neo-
adjuvant (FEC 100)/Cisplatin-Docetaxol and Trastusumab in women with
amplified Her2/neo with locally advanced breast cancer (GROG 001), April
2010.The study was presented a medical researcher at the International
conference on new frontiers in Breast Cancer, April 2010.
- Statistical analysis for the experience of King Faisal Specialist Hospital
and Research Center in the outcome of transplant of Pediatric to Adult
Allergenic Stem Cell Donation, Jun 2010.
- Statistical analysis for phase I-III trial of capecitabine, oxaliplatine and in
combination with Bevacizumab in 1
st
line treatment of metstatic colorectal
cancer, 2010.
- Experimental design and Statistical analysis for the recurrence of Fungal
Sinusitis and other factors - 2008.
- Survival analysis and survival data modeling, Oncology Cancer Center-
Research unit January 2011
5

6. NATIONAL AND INTERNATIONAL PRESENTATIONS:
- Predictive Modeling using Machine Learning Algorithms (European
Blood and Marrow Transplantation conference, March 22, 2015
-Istanbul).
- Predictive Modeling using Machine Learning Algorithms (Research day
King Faisal Specialist Hospital (KFSH&RC) May 14, 2015, Riyadh,
Saudi Arabia.
6

7. CONFERENCES AND TRAINING ATTENDED:
- European Blood and Marrow Transplantation (BMT), April 2015
(Istanbul).
- European Blood and Marrow Transplantation Statistical committee
meeting (November 2014-Paris).
- Statistical learning and data mining, Harvard Conference Center-
Harvard university , Boston - October 27-28, 2014 by
Professors Hastie and Tibshirani.
- European Blood and Marrow Transplantation (BMT), April 2014
(Milan).
- American Statistical Association (ASA) Conference on Statistical
Practices, February 2012.
- Short course, Analysis of Messy Data: Designs and Analysis of
Experiments Requiring Mixed Models. By George A. Milliken, Kansas
State University. Presented in ASA Conference, February 2012.
- Bayesian Analysis in SAS by Mike Petetta, SAS Institute. Presented in
ASA Conference, February 2012.
- Training in the statistical methodologies used in hematological field in the
Center of International Blood and Marrow Transplant CIBMTR
Milwaukee- Wisconsin for 2 weeks, April 2011.
- Oncology 4
th
Academic & Research Day, May 2010.
- International conference on new frontiers in Breast Cancer, April 2010.
- Biostatistics Research methods course at King Faisal Specialist Hospital
and Research Center, April 2009.
- Reading, writing, and publishing in Epidemiology and clinical Medicine
workshop at King Faisal Specialist Hospital and Research Center, Nov
2007.
7

8. - Advances in Endoscopic Sino-nasal Surgery International Symposium at
King Faisal Specialist Hospital and Research Center, 2009.
8

9. ABSTRACTS:
AWARDS:
 Third place of the research excellence award from the Saudi cancer foundation
2014.
Final analysis of quality-of-life assessment in lymphoma patients who underwent
high-dose chemotherapy and autologous stem cell transplant (HDC ASCT) using first
validated, translated Arabic form of FACT-BMT version (4): Single-institution
experience.
Hussein Soudy, Tusneem Elhassan, Eman M Abdullah, Ahmad Al Zahrani, Irfan
Maghfoor, Saad Akhtar.
2014 ASCO Annual Meeting abstract No: e20612
ABSTRACTS ACCEPTED AS POSTERS:
- Predicting the odds of day-100 treatment related mortality using supervised
machine learning in acute and chronic myeloid leukemia patients underwent
allogeneic stem cell transplantation: 1042 cases.
Tusneem A. Elhassan* 1, N Chaudhri1, Ghuzayel Aldawsari1, Fahad
Alsharif1, Hazzaa Alzahrani1, Said Yousuf Mohamed1, Walid Rasheed1,
Amr Hanbali1, Syed Osman Ahmed1, Marwan Shaheen1, Feras Alfraih1,
Fazal Hussain1, Fahad Almohareb1, Mahmoud Aljurf1
1Oncology Center, KING FAISAL SPECIALIST HOSPITAL & RESEACH
CENTER, Riyadh, Saudi Arabia
- MODEL COMPARISONS OF COMPETING RISKS IN AUTOLOGOUS AND
LOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: 364
LYMPHOMA AND LEUKEMIA PATIENTS
TUSNEEM A. Elhassan, Said Y. Mohamed, Saad Akhtar, Mohamed
Shoukri, N.Chaudhri, F. Hussain, Mahmoud Aljurf
EBMT 2014
- SINGLE CENTRE EXPERIENCE OF ALLOGENEIC HEMATOPOIETIC
STEM CELL TRANSPLANT (HSCT) IN HEAVILY PRE-TREATED
ADOLESCENT AND YOUNG ADULT (AYA) WITH FANCONI ANEMIA.
Ahmad Alhuraiji, Mahmoud Aljurf, Fahad Almohareb, Hazza Alzahrani,
Naeem Chaudhri, Fahad Alsharif, Walid Rasheed, Said Mohamed, Ghuzayel
Aldawsari, Amr Hanbali, Tusneem Elhassan, Syed Ahmed
EBMT 2014
- PRE-CONDITIONING IMMUNOMODULATION AND REDUCED TOXICITY
CONDITIONING (RTC) IN ALLO-SIBLINGHSCT OF ADOLESCENTS AND
YOUNG ADULTS WITH SICKLE CELL ANEMIA (SCA) AND THALASSEMIA
MAJOR(TM).
Said Y. Mohamed, Fahad Al-Mohareb, Hazzaa Alzahrani, Syed A. Osman,
Ghuzayel AlDawsary, Mahmoud Aljurf, Khaled Ibrahim, Haitham Almahayni,
Basel Al-Haji, Saleh AbuJaafar, Riad Youniss, Tussneem ElHassan.
EBMT 2014
9

10. - OUTCOME ANALYSIS OF 152 PRIMARY REFRACTORY DIFFUSE LARGE
B-CELL LYMPHOMA (DLBCL) PATIENTS YOUNGER THAN 60 YEARS
MANAGED WITH AND WITHOUT HIGH DOSE CHEMOTHERAPY AND
AUTOLOGOUS STEM CELL TRANSPLANTATION
Saad Akhtar, Hussein Soudy, Muhammad S. Rauf, Abida Rehman,
Tusneem A. M. Elhassan, Irfan Maghfoor
EBMT 2014
- SECOND LINE SALVAGE REGIMENS PRIOR TO HIGH DOSE
CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT ARE A
VALID OPTION IN PROGRESSIVE HODGKIN’S LYMPHOMA PATIENTS
REFRACTORY TO FIRST LINE SALVAGE REGIMENS
Muhammad S. Rauf, Irfan Maghfoor, Tusneem A. M. Elhassan, Saad
Akhtar.
EBMT 2014
- SOCIAL SUPPORT AND PSYCHOLOGICAL ISSUES IN HIGH DOSE
CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT
PATIENTS IN THE KINGDOM OF SAUDI ARABIA
Saad Akhtar, Hussein Soudy, Muhammad S. Rauf, Tusneem A. M.
Elhassan, Irfan Maghfoor.
EBMT 2014
- High dose chemotherapy and autologous stem cell transplantation for chemo-
sensitive primary refractory diffuse large B-cell lymphoma: prognostic factor
and survival analysis of forty-two patients.
Saad Akhtar, Tusneem A. M Elhassan, Alaa Darwish, Hussein Soudy,
Mohamed Nabil-Ahmed, Irfan Maghfoor.
EBMT 2013
- Rituximab + salvage chemotherapy (ESHAP) has superior overall and event
free survival after HDC ASCT compared to non-rituximab salvage in relapsed
and primary refractory diffuse large B-cell lymphoma patients: Integrating
rituximab in a prognostic model
Saad Akhtar, Hussein Soudy, Tusneem A. M Elhassan, Alaa Darwish,
Mohamed Nabil-Ahmed, Irfan Maghfoor
EBMT 2013
- High incidence of normal pregnancies after high dose chemotherapy and
autologous stem cell transplant in young females with non-Hodgkin’s and
Hodgkin’s lymphoma: defining and analyzing 'potential to become pregnant'
group
Saad Akhtar, Tusneem A. M Elhassan, Hussein Soudy, Iman Youssef,
Ruqaya Belkhedim, Irfan Maghfoor
EBMT 2013
- BONE MARROW CLEARANCE OF LEUKEMIC BLASTS ON DAY 14 OF
INDUCTION DETERMINES PROGNOSIS AND HELPS IN STRATIFICATION
OF ADOLESCENTS AND ADULTS WITH de novo ACUTE LYMPHOBLASTIC
LEUKEMIA
10

11. S Mohamed, K Ibrahim, H EL-Zahrany, M Bakr, M Shaheen, G El-Dossary, S
AbuJafar, S Khalil, F Al-mohareb, E Colcol, Tusneem A. M Elhassan, M
Al-Jurf, F Hussain, F AlSharif, N Chaudari KFSHRC, (Riyadh, Saudi Arabia)
EHA 2012
- Allogeneic Hematopoietic Stem Cell Transplantation from Mostly Sibling
Donors for Adolescent and Adult Patients with High-risk Acute Lymphoblastic
Leukaemia: 20-year Experience.
S. Y. Mohamed, F. Al Mohareb, G. El-Gohary, M. Bakr, W. Rasheed, F.
Alsharif, S. Abugaafar, N. Bakshi, T. Owaidah, Tusneem A. M Elhassan.
Al Zahrani, M. Aljurf, N. Chaudhri.
38
th
Annual Meeting of the European Group for Blood and Marrow
Transplantation, Volume 47 Supplement 1 April 2012.
- Favorable outcome of single locus related mismatch HSCT for class I antigen
in patients of Eastern Mediterranean background.
F. Al Mohareb, A.J.M. Saleh, M. Bakr, F. Al Sharif, H. Al Zahrani, S.Y.
Mohamed, W. Rasheed, K. Ibrahim, S. Ahmed, W. Chebbo, G. El Gohary, M.
Bashir, A. El Ghazaly, Z. Nurgat, F. Hussain, T. El Hassan, N. Chaudhri, M.
Aljurf (Riyadh, SA).
Abstract, EBMT Annual Meeting, 3-6 April 2011.
- Impact of Primary Trastuzumab with Chemotherapy on Pathological Response
in Patients with Locally Advanced Breast cancer and Advanced Breast Cancer
(A single Institution experience)
Alsayed A1; Al Hashem,H2; Almashaikhi, M2; Al Hayli,S2 ; Sajjad, MH3; Twejieri, T1;
Suleman, K1; T. ElHassan T4; Ajarim D1.
- Impact of surface CD20 expression on prognosis of adolescents and young
adults with pre-B acute lymphoblastic leukaemia treated with a unifiedrisk-
stratified protocol.
S. Mohamed, G. ElGohary, M. AlJurf, F. AlMohareb, K. Ibrahim, M. Bakr, S. AbuJafar,
W. Chebbo, S. Ahmed, M. Albitar, R. Al-Nounou, T. ElHassan, N. Chaudari, H.
AlZahrani, W. Rasheed. KFSHRC (Riyadh, SA)
38
th
Annual Meeting of the European Group for Blood and Marrow
Transplantation, Volume 47 Supplement 1 April 2012
- Outcome of Autologous Hematopoietic Stem Cell Transplantation in Adults
with Acute Myeloid Leukemia using three different conditioning regimens.
W. Rasheed, F. Al Mohareb, M. Bakr, N. Chaudhri, F. Alsharif, S.Y. Mohamed, AJM
Saleh, K. Ibrahim, S. Ahmed, W. Chebbo, G. El Gohary, M. Bashir, A. Elghazaly, Z.
Nurgat, F. Hussain, T. ElHassan, M. Aljurf, H. Al Zahrani.
Abstract, EBMT Annual Meeting, 3-6 April 2011.
- Prognostic Significance of International Prognostic Index(IPI) Individual Risk
11

12. Factors in Patients with Diffuse Large B Cell Lymphoma(DLBCL) treated with
Rituximab (R ) and CHOP (R-CHOP) based chemotherapy.
Akhtar S, Shoudy H, Bakshi N, Rehman A, Abdelsalam M, Elhassan T, Nabil M,
Magfoor I.
The European CanCer Organization (ECCO) 2013.
____________________________________________________________
- International Prognostic Index(IPI) is a stronger Predictive of Outcome
in Diffuse Large B Cell Lymphoma (DLBCL) Treated with Rituximab
(R) and CHOP (R-CHOP) Compared to revised-IPI (R-IPI).
Soudy H, Akhtar S, Bakshi N, Rehman A, Abdelsalam M, Darwish A, Ahmed M.N,
Magfoor I.
The European CanCer Organization (ECCO) 2013.
___________________________________________________________
- Early stage large B-cell lymphoma treated with CHOP with or without
rituximab (R): outcome analysis according to risk stratification.
Magfoor I, Soudy H, Bakshi N, Rehman A, Abdelsalam M, Darwish
A,Elhassan T, Ahmed M.N, Akhtar.
The European CanCer Organization (ECCO) 2013.
__________________________________________________________
- Traztuzumab with chemotherapy in locally advanced breast cancer.
Alsyed AD et al.
ABSTRACTS ACCEPTED AS ORAL PRESENTATION:
- Pre-transplant FDG-PET scan response and other prognostic factors based
survival model in patients with relapsed and refractory Hodgkin’s lymphoma is
useful to predict outcome after high dose chemotherapy and autologous stem
cell transplant.
Saad Akhtar, Abdulaziz S Al-Sugair, Moheieldin Abouzied, Yusuf AlKadhi,
Mahmoud Abdelsalam, Marybeth Dingle, Hussein Soudy, Alaa Darwish, Amin
Eltigani, Tusneem Ahmed M Elhassan, Mohamed Nabil-Ahmed, Irfan
Maghfoor
EBMT 2013 / LONDON ORAL PRESENTATION
PUBLICATION:
- Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic
Hematopoietic Stem Cell Transplantation.
J Transplant. 2014;2014:980301. doi: 10.1155/2014/980301. Epub 2014 Oct 27
Nassar A1
, Elgohary G2
, Elhassan T3
, Nurgat Z4
, Mohamed SY2
, Aljurf M3
1
National Research Center, Tahrir Street, Cairo, Egypt.2
Adult HSCT Program, Ain
Shams University Hospitals, P.O. Box 1156, Cairo, Egypt. 3
Adult HSCT Program,
Oncology Center, King Faisal Specialist Hospital & Research Center, P.O. Box 3354,
Riyadh 11211, Saudi Arabia. 4
Pharmaceutical Care Division, King Faisal Specialist
Hospital & Research Center, P.O. BOX 3354, Riyadh 11211, Saudi Arabia.
12

13. - Pre-transplant (18)F-fluorodeoxyglucose positron emission tomography-
based survival model in patients with aggressive lymphoma undergoing
high-dose chemotherapy and autologous SCT.
Akhtar S, Al-Sugair AS, Abouzied M, Alkadhi Y, Dingle M, Abdelsalam M,
Soudy H, Darwish A, Eltigani A, Elhassan TA, Nabil-Ahmed M, Maghfoor I.
Bone Marrow Transplant.2013 Apr; 48(4):551-6.doi: 10.1038/bmt.2012.168.
Epub 2012 Sep 10
- Allogeneic hematopoietic stem cell transplantation in adolescent and
adult patients with high-risk T cell acute lymphoblastic leukemia.
Bakr M, Rasheed W, Mohamed SY, Al-Mohareb F, Chaudhri N, Al-Sharif F,
Al-Zahrani H, Al-Dawsari G, Saleh AJ, Nassar A, Ahmed S, Elghazaly A,
Ahmed SO, Ibrahim K, Chebbo W, El Gohary GM, Al Mahayni MH, Hussain
F, Nurgat Z, Elhassan TA, Walter CU, Aljurf M.
Biol Blood Marrow Transplant. 2012 Dec;18(12):1897-904. doi: 10.1016/j.bbmt.
2012.07.011. Epub 2012 Jul 21
- Fludarabine-based conditioning chemotherapy for allogeneic
hematopoietic stem cell transplantation in acquired severe aplastic
anemia
Al-Zahrani H, Nassar A, Al-Mohareb F, Al-Sharif F, Mohamed S, Al-Anazi K,
Patel M, Rasheed W, Saleh AJ, Bakr M, Ahmed S, Ibrahim K, Hussain F,
Elkum N, Elhassan T, Nurgat Z, Chaudhri N, Aljurf M.
Biol Blood Marrow Transplant. 2011 May;17(5):717-22. doi:
0.1016/j.bbmt.2010.08.013. Epub 2010 Aug 22
- Predictors of cure, amputation and follow-up dropout among patients
with mycetoma seen at the Mycetoma Research Centre, University of
Khartoum, Sudan.
Zein HA, Fahal AH, Mahgoub el S, El Hassan TA, Abdel-Rahman ME.
Trans R Soc Trop Med Hyg. 2012 Nov;106(11):639-44. doi:
10.1016/j.trstmh.2012.07.003. Epub 2012 Jul 31.PMID:22854685 [PubMed -
indexed for MEDLINE]
- Outcome of Autologous Hematopoietic Stem Cell Transplantation in
Adults with Acute Myeloid Leukemia using three different conditioning
regimens.
W. Rasheed, F. Al Mohareb, M. Bakr, N. Chaudhri, F, Alsharif, S.Y. Mohamed,
AJM Saleh, K. Ibrahim, S. Ahmed, W. Chebbo, G. El Gohary, M.Bashir, A.
Elghazaly, Z. Nurgat, F. Hussain, T. ElHassan, M.Aljurf, H. Al Zahrani.
Bone Marrow Transplantation (Impact Factor: 3.47). 01/2010.
EBMT. Dec 2010
13

14. - Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2011.
Fazal Hussain, Samra Iqbal, Asif Mehmood, Shouki Bazarbashi, Tusneem
Elhassan, Naeem Chaudhri
Hematology/ Oncology and Stem Cell Therapy 06/2013;
DOI:10.1016/j.hemonc.2013.05.004 Source: PubMed
- Incidence of Malignant Ovarian Germ Cell Tumors (MOGCT) in Saudi
Arabia
Ahmed Abu-Zaid,Ahmed Nazer, Osman Alomar,Ayman Azzam,Haya S.Al-
Eid ,Tusneem Ahmed Elhassan, Isail A.Al-Badawi
RESEARCH INTERESTS:
- Statistical machine learning using (Artificial Neural Networks (ANN),
Support Vector Machines (SVM) and Random Forests.
- Survival analysis.
- Survival Data modeling in presence of competing ricks.
- Survival Data modeling and time dependent covariates.
- longitudinal data analysis
- Categorical data analysis
MEMBERSHIP:
European Bone Marrow Transplantation Statistical committee -April 2014
Aug.2011-present American Statistical Association
TECHNICAL SKILLS:
Statistics:
- Multivariate analysis (MLR, MANOVA, etc.), non-parametric methods,
categorical analysis, time-to event analysis.
Research methodology:
- Questionnaire and Case Report Form (CRF) designs, experimental
design and sampling techniques.
STATICTICAL Software:
- SAS
- STATA
- SPSS
14

15. - R-Project
- MatLab
Programming Languages:
- C++
- Pascal
- Java
.Net Applications:
- C#
- Visual Basic.net
- Jsp.Net
Web Design Skills:
- HTML, Dynamic HTML
- FrontPage, Dream Weaver
- Java Script (Client-Side scripting)
- Extensible Markup Language (XML)
Database System skills:
- MS-Access
- SQL Server 2000
- Oracle9i & 10g
Other Technical skills:
- Distributed Systems
- Object Oriented Programming and RDBMS.
- Database designing and architecture.
- Client-Server and multi-tier architecture.
- Able to manage, analyze, design, develop, implement and support
software systems.
PERSONAL SKILLS:
1 Good presentation and communication skills.
2 Self-motivated.
3 Active team member and have good team inspiring, motivational and
leadership skills.
15

16. 4 Able to work under pressure and handling difficult situations.
REFERENCES:
Prof.Mohamed Shokri, Department of Biostatistics and Scintific computing at
King Faisal Specialist Hospital and Research Center. shoukri@kfshrc.edu.sa
Dr. Edward B. De Vol, Chair, Biostatistics, Epidemiology, and Scientific
Computing at King Faisal Specialist Hospital and Research Centre
edevol@kfshrc.edu.sa
Dr. Hisham Abu Shama, University of Khartoum, +249912314600
Dr. Gada Kadoda, University of Khartoum, +249922599843
Eng. Hassan M. Hassan, Arabic Computer Systems Ltd., +966 504265141
Eng. Alags Alagaban, Aptech Computer Eduaction, +249912912468
Dr. Mahmoud Ali, University of Khartoum, +249912269788
Dr. Syed Saad Akhtar, Consultant, Medical Oncology Department: Oncology
Center sakhtar@kfshrc.edu.sa
16